Understanding how a specific bacteria affects lung cells and immune response
Structure and Function of Legionella pneumophila Lysine Methyltransferases
This study is looking at how a bacteria that causes Legionnaires' Disease affects lung cells, especially in older adults and those with weaker immune systems, to find new ways to help treat the illness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11023142 on NIH RePORTER |
What this research studies
This research investigates Legionella pneumophila, a bacteria that causes Legionnaires' Disease, particularly in older adults and those with weakened immune systems. The study focuses on how this bacteria manipulates host cell functions to enhance its survival and replication, specifically through proteins called lysine methyltransferases. By examining the molecular interactions and effects of these proteins on gene expression in lung cells, the research aims to uncover critical insights into the disease process and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are elderly individuals or those with compromised immune systems or chronic lung diseases who are at risk for Legionnaires' Disease.
Not a fit: Patients who are healthy and do not have risk factors for Legionnaires' Disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for Legionnaires' Disease and improve outcomes for vulnerable patient populations.
How similar studies have performed: Previous research has shown success in understanding bacterial pathogenesis through similar molecular approaches, indicating potential for impactful findings in this area.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Trievel, Raymond C — University of Michigan at Ann Arbor
- Study coordinator: Trievel, Raymond C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.